Abstract
Schistosomiasis is a tropical parasitic disease, in which the major clinical manifestation includes hepatosplenomegaly, portal hypertension, and organs fibrosis. Clinically, treatment of schistosomiasis involves the use of praziquantel (PZQ) and supportive care, which does not improve the patient’s outcome as liver injuries persist. Here, we report for the first time the effect of N-acetyl-L-cysteine (NAC) and/or praziquantel (PQZ) on S. mansoni, hepatic granuloma, serum markers for liver function and oxidative damage in acute schistosomiasis. Infected mice were divided into control, NAC, PZQ and NAC+PZQ groups and uninfected into control and NAC groups. After infection, NAC (200 mg/kg/day) was administrated until the 60th day and PZQ (100 mg/kg/day) from the 45th to the 49th day, both orally. On day 61, the mice were euthanized for serum markers for liver function. Worms were recovered, fragments of intestine employed to ascertain the oviposition pattern, and the liver was used for histopathological analysis, histomorphometry, egg and granuloma counting and oxidative stress marker assays. NAC reduced the burden of worms and eggs and increased the dead eggs in intestinal tissue. NAC+PZQ brought about reduction in granulomatous infiltration and NAC and/or PZQ reduced levels of ALT, AST, and alkaline phosphatase and increased albumin. NAC, PZQ or NAC+PZQ reduced levels of the superoxide anion, lipid peroxidation and protein carbonyl and increased sulfhydryl groups. The reduction in parasitological parameters, granulomatous inflammation and oxy-redox imbalance suggests NAC acts as a adjuvant in treatment of acute experimental schistosomiasis.
Similar content being viewed by others
Data availability
Data will be made available upon request.
References
Abdallahi OM, Hanna S, De Reggi M, Gharib B (1999) Visualization of oxygen radical production in mouse liver in response to infection with Schistosoma mansoni. Liver Int 19:495–500. https://doi.org/10.1111/j.1478-3231.1999.tb00082.x
Abdul-Ghani R, Loutfy N, Sheta M, Hassan A (2011) Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection. Parasitol Res 108:1199–1205. https://doi.org/10.1007/s00436-010-2163-9
Aires AL, Albuquerque MCPA, Silva RA, Schirato GV, Pontes Filho NT, Araújo SB, Souza VM, Costa VM, Malagueño E (2012) Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine. Parasitol Res 111:1569–1578. https://doi.org/10.1007/s00436-012-2997-4
Allam G (2009) Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiology 214:712–727. https://doi.org/10.1016/j.imbio.2008.11.017
Araújo HDA, Aires AL, Soares CLR, Brito TGS, Nascimento WM, Martins MCB, Silva TG, Brayner FA, Alves LC, Silva NH, Albuquerque MCPA, Lima VLM (2019) Usnic acid potassium salt from Cladonia substellata (Lichen): synthesis, cytotoxicity and in vitro anthelmintic activity and ultrastructural analysis against adult worms of Schistosoma mansoni. Acta Trop 192:1–10. https://doi.org/10.1016/j.actatropica.2018.12.024
Araújo HDA, Santos VHB, Brayner FA, Alves LC, Silva NH, Albuquerque MCPA, Aires AL, Lima VLM (2020a) In vitro activity of usnic acid potassium salt against different developmental stages of Schistosoma mansoni: an ultrastructural study. Acta Trop 201:1–11. https://doi.org/10.1016/j.actatropica.2019.105159
Araújo HDA, Silva NH, Albuquerque MCPA, Aires AL, Lima VLM (2020b) Potassium usnate, a water-soluble usnic acid salt, shows enhanced activity against Schistosoma mansoni in vitro. Exp Parasitol 208:1–5. https://doi.org/10.1016/j.exppara.2019.107779
Cacciatore I, Cornacchia C, Pinnen F, Mollica A, Di Stefano A (2010) Prodrug approach for increasing cellular glutathione levels. Molecules 15:1242–1264. https://doi.org/10.3390/molecules15031242
Cai Z, Lou Q, Wang F, Li E, Sun J, Fang H, Xi J, Ju L (2015) N-acetylcysteine protects against liver injure induced by carbon tetrachloride via activation of the Nrf2/HO-1 pathway. Int J Clin Exp Pathol 8:8655–8662
Carvalho-Queiroz C, Nyakundi R, Ogongo P, Rikoi H, Egilmez NK, Farah IO, Kariuki TM, LoVerde PT (2015) Protective potential of antioxidant enzymes as vaccines for schistosomiasis in a non-human primate model. Front Immunol 2:1–16. https://doi.org/10.3389/fimmu.2015.00273
Cheever AW (1968) Conditions affecting the accuracy of potassium hydroxidedigestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ 39:328–331
Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23–38. https://doi.org/10.1016/s0009-8981(03)00003-2
Dkhil MA, Bauomy AA, Diab MS, Al-Quraishy S (2015) Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis. Int J Nanomedicine 16:7467–7475. https://doi.org/10.2147/IJN.S97622
Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431. https://doi.org/10.1016/0076-6879(90)86135-i
El-Lakkany NM, El-Din SH, Sabra AA, Hammam OA (2001) Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni. Mem Inst Oswaldo Cruz 106:814–822. https://doi.org/10.1590/S0074-02762011000700006
El-Lakkany NM, Seif El-Din SH, Sabra AA, Hammam OA, Ebeid FA (2016) Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver. Res Pharm Sci 11:374–382. https://doi.org/10.4103/1735-5362.192487
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77. https://doi.org/10.1016/0003-9861(59)90090-6
Fan ZG, Zhang LM, Li KJ, Li W, Zhu PX, Yang G (2007) Effect of N-acetylcysteine on the egg granuloma in hepatic tissue of mice with schistosomiasis japonica. Chin J Parasitol Parasit Dis 25:137–140
Fan ZG, Li KJ, Zhang LM (2011) Effect of N-acetylcysteine on malondialdehyde and superoxide dismutase in hepatic tissue of mice with Schistosomiasis japonica. Chin J Parasitol Parasit Dis 29:457–460
Galicia-Moreno M, Favari L, Muriel P (2012) Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model. Eur J Gastroenterol Hepatol 24:179–185. https://doi.org/10.1097/MEG.0b013e32834f3123
Herbert DR, Orekov T, Perkins C, Finkelman FD (2008) IL-10 and TGF-β redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 181:7214–7220. https://doi.org/10.4049/jimmunol.181.10.7214
Huang HH, Rigouin C, Williams DL (2012) The redox biology of schistosome parasites applications for drug development. Curr Pharm Des 18:3595–3611. https://doi.org/10.2174/138161212801327220
Jones AL, Bangash IH, Bouchier IA, Hayes PC (1994) Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 35:1290–1293. https://doi.org/10.1136/gut.35.9.1290
Kwatia MA, Botkin DJ, Williams DL (2000) Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin peroxidase. J Parasitol 86:908–915. https://doi.org/10.1645/0022-3395(2000)086[0908:MAECOS]2.0.CO;2
Lee EJ, Silva SM, Simões MJ, Montero EF (2012) Effect of N-acetylcysteine in liver ischemia-reperfusion injury after 30% hepatectomy in mice. Acta Cir Bras 27:346–349. https://doi.org/10.1590/s0102-86502012000400011
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464–478. https://doi.org/10.1016/0076-6879(90)86141-h
Licks F, Marques C, Zetler C, Martins MI, Marroni CA, Marroni NP (2014) Antioxidant effect of N-acetylcysteine on prehepatic portal hypertensive gastropathy in rats. Ann Hepatol 13:370–377. https://doi.org/10.1016/S1665-2681(19)30867-1
Mata-Santos HA, Dutra FF, Rocha CC, Lino FG, Xavier FR, Chinalia LA, Hossy BH, Castelo-Branco MT, Teodoro AJ, Paiva CN, Pyrrho AS (2014) Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis. Antimicrob Agents Chemother 58:2076–2083. https://doi.org/10.1128/AAC.01936-13
Mei H, LoVerde PT (1997) Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. Exp Parasitol 86:69–78. https://doi.org/10.1006/expr.1997.4150
Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175. https://doi.org/10.1016/S0021-9258(19)45228-9
Ntamo Y, Ziqubu K, Chellan N, Nkambule BB, Nyambuya TM, Mazibuko-Mbeje SE, Gabuza KB, Marcheggiani F, Tiano L, Dludla PV (2021) Drug-induced liver injury: clinical evidence of N-acetyl cysteine protective effects. Oxid Med Cell Longev 2021:1–12. https://doi.org/10.1155/2021/3320325
Oliveira RB, Senger MR, Vasques LM, Gasparotto J, Santos JP, Pasquali MA, Moreira JC, Silva FP Jr, Gelain DP (2013) Schistosoma mansoni infection causes oxidative stress and alters receptor for advanced glycation endproduct (RAGE) and tau levels in multiple organs in mice. Int J Parasitol 43:371–379. https://doi.org/10.1016/j.ijpara.2012.12.006
Olivier L, Stirewalt MA (1952) An efficient method for exposure of mice to cercariae of Schistosoma mansoni. J Parasitol 38:19–23. https://doi.org/10.2307/3274166
Pellegrino J, Oliveira CA, Faria J, Cunha AS (1962) New approach to the screeningof drugs in experimental Schistosomiasis mansoni in mice. Am J Trop Med Hyg 11:201–215. https://doi.org/10.4269/ajtmh.1962.11.201
Pereira-Filho G, Ferreira C, Schwengber A, Marroni C, Zettler C, Marroni N (2008) Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats. Arq Gastroenterol 45:156–162. https://doi.org/10.1590/s0004-28032008000200013
Rushworth GF, Megson IL (2014) Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther 141:150–159. https://doi.org/10.1016/j.pharmthera.2013.09.006
Sargent MG (1987) Fiftyfold amplification of the Lowry protein assay. Anal Bioch 163:476–481. https://doi.org/10.1016/0003-2697(87)90251-x
Seif El-Din SH (2006) Protective effects of β-carotene; N-acetyl-L-cysteine with and without praziquantel treatment in Schistosoma mansoni-infected mice. Egypt J Schistosomiasis Infect Endem Dis 28:67–90
Seif El-Din SH, El-Lakkany NM, Hagag HA, Ebeid FA (2010) Role of B-carotene and N-acetyl-L-cysteine with and without praziquantel treatment in modulating Schistosoma mansoni-induced genotoxic effects on albino mice. Res J Medicine and Med Sci 5:8–17
Seif El-Din SH, Al-Hroob AM, Ebeid FA (2011) Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice. Exp Parasitol 128:230–235. https://doi.org/10.1016/j.exppara.2011.03.006
Simeonov A, Jadhav A, Sayed AA, Wang Y, Nelson ME, Thomas CJ, Inglese J, Williams DL, Austin CP (2008) Quantitative high throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Negl Trop Dis 2:1–10. https://doi.org/10.1371/journal.pntd.0000127
Smithers SR, Terry RJ (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695–700. https://doi.org/10.1017/s0031182000086248
Soliman RH, Ismail OA, Badr MS, Nasr SM (2017) Resveratrol ameliorates oxidative stress and organ dysfunction in Schistosoma mansoni infectedmice. Exp Parasitol 174:52–58. https://doi.org/10.1016/j.exppara.2017.02.008
Takhtfooladi MA, Jahanshahi G, Jahanshahi A, Sotoudeh A, Amlashi OS, Allahverdi A (2014) Effects of N-acetylcysteine on liver remote injury after skeletal muscle ischemia reperfusion in rats. Turk J Gastroenterol 25:43–47. https://doi.org/10.5152/tjg.2014.6008
Tendler M, Pinto RM, Lima AO, Gebara G, Katz N (1968) Schistosoma mansoni: vaccination with adult worm antigen. Int J Parasitol 16:347–352. https://doi.org/10.1016/0020-7519(86)90113-x
World Health Organization (2023) Schistosomiasis. Fact sheet detail. http://www.who.int/news-room/fact-sheets/detail/schistosomiasis. Accessed 7 Feb 2023
Yepes E, Varela-M RE, López-Abán J, Rojas-Caraballo J, Muro A, Mollinedo F (2015) Inhibition of granulomatous inflammation and prophylactic treatment of schistosomiasis with a combination of edelfosine and praziquantel. PLoS Negl Trop Dis 9:1–22. https://doi.org/10.1371/journal.pntd.0003893
Acknowledgements
This work received financial support from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES—Grant Nº.001) and Fundação de Amparo a Ciência e Tecnologia do Estado de Pernambuco (FACEPE). H.D.A. Araújo thanks FACEPE for the Researcher Fixation Scholarship (BFP-0080-2.08/20).
Author information
Authors and Affiliations
Contributions
AdLA and MCPdAA: Albuquerque designed the study protocol. AdLA, HDAdA, AMG, SBdA, RLdS, ZPdA, MBdSM, VMOS and MCPdAA: carried out the assays and/or were involved in the analysis and interpretation of all data. AdLA, HDAdA, VMOS and MCPdAA: contributed to drafting the manuscript and/or critically revising the paper and intellectual content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflicts of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
de Lima Aires, A., de Araújo, H.D.A., Galvão, A.M. et al. Schistosomicidal, hepatoprotective and antioxidant activities of the N-acetyl-L-cysteine and/or praziquantel in experimental acute mansonic schistosomiasis. 3 Biotech 13, 215 (2023). https://doi.org/10.1007/s13205-023-03639-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-023-03639-3